This risk assessment is triggered by the increase in the number of yellow fever cases among EU travellers with exposure in South America since August 2016 and assesses the risk of contracting yellow fever for travellers to South America.
An outbreak of S. Enteritidis phage type 8 is ongoing in the EU/EEA. Isolates are part of two distinct but related genetic clusters. ECDC and EFSA are liaising with relevant authorities to facilitate the coordination of investigation response measures.
This rapid risk assessment assesses the recurrent multi-country outbreak of Salmonella Enteritidis due to a persistent source of infection, with current or recent exposure in at least four EU/EEA Member States.
This updated rapid risk assessment gives an overview of an increase in the number of Salmonella Stourbridge cases in Germany during the second half of 2016, with other EU Member States also reporting cases.
This rapid risk assessment looks at the reported increase in the number of Salmonella Stourbridge cases in Germany and other EU countries during the second half of 2016.
This publication assesses the risk of Salmonella infection associated with exposure to feeder mice in the context of a multi-country outbreak of S. Enteritidis PT 8 infection, characterised by MLVA type 2-10-8-5-2.
ECDC conducted a systematic review of the literature published between 2005–2015, with the aim to estimate the prevalence of hepatitis B and C in the general population and specific population subgroups in the EU/EEA Member States. This review is an update of an earlier review covering the period 2000–2009.
This update of ECDC’s rapid risk assessment on the Zika epidemic considers the recent epidemiological and scientific information in light of the risk to Europe and European citizens.